Finding the Consumer Within the Patient: Insights Into How Healthcare Decisions are Made

Self Care Catalysts' Patient Intelligence Insights Guide™ on Diabetes is the only integrated patient-and consumer-centric report that explores how people suffering from an invisible condition such as diabetes actually circumnavigate their health condition, using the unique Self Care Health Decision Making Dynamics framework™. It is an example of what Grace Soyao, Founder & Chief Strategy Officer of Self Care Catalysts Inc., a health research and strategy company, means by 'Finding the Consumer within the Patient.'

Adverse Event Reporting: A Missed Opportunity

When asked what the # 1 concern pharmaceutical marketers have regarding using social media, the adverse event reporting (AER) boogey man is cited most often. The urge to avoid this boogey man at all costs may have more to do with CEO compensation that with fears of rank-an-file marketers.

Deconstructing Pitts’ Guiding Principles for Pharma Social Media

Peter Pitts, author of DrugWonks Blog, has put together 11

Will Critics Kill Pharma’s Social Media Golden Egg Laying Goose?

The fear is that if the first steps by pharma to engage in social media conversation are too harshly scrutinized and criticized, the drug industry will shy away from getting more involved in social media.

The Pozen Digital Advisory Board

A conversation with Elizabeth A. Cermak, EVP, and Chief Commercial Officerat Pozen, Raj Amin, CEO and Co-Founder of HealthiNation, and Bonin Bough, Senior Global Director of Digital and Social Media, PepsiCo, about the who, what, why behind the Pozen Digital Advisory Board, an esteemed group of digital thought-leaders both in and outside of healthcare.

Double Dip in DTC Ad Spend!

Direct-to-Consumer (DTC) pharmaceutical advertising spending suffered a 'double dip' recession between 2007 and 2010, according to data presented in the AdAge Insights Whitepaper

Pharma Marketing News Vol. 10, No. 9: 18 May 2011

Welcome to Volume 10, Issue #9 (18 MAY 2011) of Pharma Marketing News.

A New Estimate of Drug Development Cost

Economic Experts Disagree Wildly on How Much It Costs to Bring a New Drug to Market. How is it that the Tufts estimate is at least 14 TIMES the London School of Economics and Political Science (LSEPS) estimate? 'Make no mistake,' said Tufts. 'Tufts CSDD will vigorously defend the scholarship, integrity, and validity of all its published research studies.'

Breaking the 140-character Limit of Twitter

Opening the Door to FDA-Compliant Branded Tweets: has enormous potential for pharmaceutical marketers who have been chaffing at the bit to post meaningful branded messages via Twitter but who have been stymied by lack of guidance from FDA regarding how to provide fair balance within the 140-character limit of Twitter.

Pharma Marketing News Vol. 10, No. 18: 1 December 2011

Welcome to Volume 10, Issue #18 (1 DECEMBER 2011) of Pharma Marketing News.
- Advertisement -